Drug intelligence / Profile preview

AMA1-DiCo

Development stage
Phase 1
Lead developer
Inserm
Modality
Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
Administration
Intramuscular
01

Overview

**AMA1-DiCo** is an investigational recombinant protein-subunit malaria vaccine designed to prevent *Plasmodium falciparum* malaria. It contains three diversity-covering recombinant variants of *P. falciparum* apical membrane antigen 1, a polymorphic parasite protein involved in host-cell invasion. The multivariant antigen design aims to induce broadly cross-reactive anti-AMA1 antibodies against genetically diverse parasite strains. AMA1-DiCo was evaluated in a completed randomized Phase 1a/1b study in malaria-naive European adults and malaria-exposed African adults, administered intramuscularly with either GLA-SE or Alhydrogel as an adjuvant.

Other names
AMA1-DiCoAMA-1-DiCoAMA 1-DiCoPfAMA1 DiCoPfAMA-1 DiCoPfAMA 1 DiCoPfAMA1-DiCoPfAMA-1-DiCoPfAMA 1-DiCo
02

Targets

AMA1 (Apical membrane antigen 1)

Beyond the preview

Go deeper on AMA1-DiCo.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on AMA1-DiCo.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call